Heart Doc VIP with Dr. Joel Kahn

In this bonus episode, Dr. Joel Kahn interviews Dr. James Min, founder and CEO of Cleerly Health.

Cleerly Health is revolutionizing heart diagnostics with their software, which analyzes coronary CT angiograms (CCTA) using AI to detect and evaluate heart plaque.

Not all plaque is equal, and Cleerly Health focuses on identifying non-calcified or "soft" plaques, which are the most dangerous and most likely to be reversible.

This cutting-edge technology has been employed hundreds of times at the Kahn Center, offering a new paradigm in heart health assessment and treatment.

Remember to register for the Reversing Heart Disease Summit 3.0 starting next week, March 18th. drtalks.com/summit/reversing-heart-disease/

Tom Rifai, MD is a visionary and expert on metabolic health, insulin resistance, diabetes, and overall fitness. He has had his own journey into metabolic disease but has found his way out. He is a member of the Cleveland Clinic’s Endocrine & Metabolism team in the Medical Specialties Institute.

In this week's brief Heart Doc VIP Podcast episode, Dr. Joel Kahn explores a recent study underscoring the importance of consistent physical activity and the risks associated with excessive sitting. He also shares experiences from the Kahn Center regarding the diabetes regression program at L-nutrahealth.com. Note the new schedule: transitioning from Fridays, the podcast will release its next full, 25-minute episode on Tuesday next week, and then continue with new episodes every Tuesday thereafter.

The online summit "Reversing Heart Disease Naturally" is about to begin on 2/28/23 and you can sign up here today.

This week Dr. Kahn takes on 3 topics including intermittent fasting, alcohol and the brain, and a "New Paradigm" for stable coronary artery disease (CAD). He discusses data that not all angina chest pain is from narrowed large arteries and not all angina responds to stents and bypass surgery. A more comprehensive and measured approach is described that will avoid invasive procedures in many patients.

Those well-versed in plant-based medicine recognize that the reversal of coronary artery disease is possible, drawing from the pioneering work of experts like Pritikin, Ornish, Esselstyn, and Fuhrman. Yet, many in the broader cardiology world may not fully grasp the depth of this potential.

This week, Dr. Kahn sheds light on a groundbreaking study from a leading medical journal, underscoring the tangible benefits of heart disease reversal in decreasing cardiac events. When lifestyle modifications are paired with the right pharmaceuticals, the result is a formidable defense against atherosclerosis. We're on the brink of exhilarating advancements.